NewSquare Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
49,037
+8,152
+20% +$1.76M 0.9% 23
2026
Q1
$8.21M Buy
+40,885
New +$8.46M 0.71% 30
2020
Q1
Sell
-90
Closed -$13K 366
2019
Q4
$13K Sell
90
-185
-67% -$25.4K ﹤0.01% 220
2019
Q3
$34K Sell
275
-118,032
-100% -$15.7M 0.01% 155
2019
Q2
$16.7M Buy
118,307
+3,217
+3% +$444K 3.04% 12
2019
Q1
$17.4M Buy
115,090
+1,540
+1% +$222K 3.31% 11
2018
Q4
$14.1M Buy
113,550
+5,705
+5% +$780K 2.98% 12
2018
Q3
$17.1M Buy
+107,845
New +$16.3M 3.24% 12
2016
Q4
Sell
-45
Closed -$4K 366
2016
Q3
$4K Hold
45
﹤0.01% 347
2016
Q2
$4K Hold
45
﹤0.01% 293
2016
Q1
$4K Sell
45
-138,543
-100% -$12.2M ﹤0.01% 358
2015
Q4
$15.7M Buy
138,588
+13,715
+11% +$1.48M 4.39% 6
2015
Q3
$12.7M Buy
124,873
+12,961
+12% +$1.54M 3.73% 9
2015
Q2
$13.9M Buy
111,912
+16,375
+17% +$1.98M 4.12% 4
2015
Q1
$11.3M Buy
95,537
+25,377
+36% +$2.87M 3.47% 5
2014
Q4
$7.16M Buy
70,160
+10,810
+18% +$1.06M 2.41% 14
2014
Q3
$5.45M Buy
59,350
+15,295
+35% +$1.33M 1.94% 13
2014
Q2
$3.63M Buy
44,055
+18,575
+73% +$1.42M 1.3% 32
2014
Q1
$1.95M Buy
25,480
+24,440
+2,350% +$1.91M 0.79% 41
2013
Q4
$72K Buy
+1,040
New +$68.2K 0.03% 108

Other funds holding FBT

NewSquare Capital's FBT Position: Q2 2026 in Review

NewSquare Capital increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 20% in Q2 2026, buying an estimated $1.76M and bringing the position to 49,037 shares worth $12.2M. The position accounts for 0.9% of the portfolio, ranked #23.

NewSquare Capital first reported a position in FBT in Q4 2013 and has held it in 20 quarters since. The position peaked at $17.4M in Q1 2019. 143 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • NewSquare Capital held 49,037 shares of First Trust NYSE Arca Biotechnology Index Fund worth $12.2M as of Q2 2026.
  • NewSquare Capital bought 8,152 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.76M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.9% of NewSquare Capital's portfolio in Q2 2026, its #23 holding.
  • NewSquare Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and has held it in 20 quarters since.
  • NewSquare Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $17.4M in Q1 2019.
  • 143 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on NewSquare Capital's 13F filing for Q2 2026, filed 28 Jul 2026.